老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ultragenyx Pharmaceutical Inc

26.31
-1.1000-4.01%
盤後：26.20-0.1100-0.42%19:56 EDT
成交量：390.58萬
成交額：1.04億
市值：24.83億
市盈率：-4.48
高：27.89
開：27.41
低：26.00
收：27.41
資料載入中...
總覽公司新聞公告
2020/05/13

重要事件披露

8-K - Current report
2020/05/11

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/05/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/04/01

重要事件披露

Current report, items 3.02, 8.01, and 9.01
2020/03/06

重要事件披露

8-K - Current report
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/02/13

重要事件披露

Current report, items 2.02 and 9.01
2020/02/13

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/06

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 2.02, 7.01, 8.01, and 9.01
2020/01/09

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2020/01/08

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
更多